Warfarin

Displaying 1 - 5 of 5CSV
Anandalwar, S. P., O’Meara, L., Vesselinov, R., Zhang, A., Baum, J. N., Cooper, A., Decker, C., Schroeppel, T., Cai, J., Cullinane, D., Catalano, R. D., Bugaev, N., LeClair, M., Feather, C., McBride, K., Sams, V., Leung, P. S., Olafson, S., Callahan, D. S., … Ghneim, M. (2024). Warfarin, not direct oral anticoagulants or antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: Implications in this new era of novel anticoagulants: An EAST multicenter study. Journal of Trauma and Acute Care Surgery, 97(2), 225–232. https://doi.org/10.1097/ta.0000000000004278
Publication Date
Romiti, G. F., Nabrdalik, K., Corica, B., Bucci, T., Proietti, M., Qian, M., Chen, Y., Thompson, J. L. P., Homma, S., & Lip, G. Y. H. (2024). Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial. Internal and Emergency Medicine, 19(4), 931–939. https://doi.org/10.1007/s11739-024-03544-4
Publication Date
Gue, Y., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (2023). Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. The American Journal of Medicine, 136(11), 1099-1108.e2. https://doi.org/10.1016/j.amjmed.2023.07.019
Publication Date
O’Meara, L., Zhang, A., Baum, J. N., Cooper, A., Decker, C., Schroeppel, T., Cai, J., Cullinane, D. C., Catalano, R. D., Bugaev, N., LeClair, M. J., Feather, C., McBride, K., Sams, V., Leung, P. S., Olafson, S., Callahan, D. S., Posluszny, J., Moradian, S., … Ghneim, M. (2023). Anticoagulation in emergency general surgery: Who bleeds more? The EAST multicenter trials ACES study. Journal of Trauma and Acute Care Surgery, 95(4), 510–515. https://doi.org/10.1097/ta.0000000000004042
Publication Date
Yang, X., Wang, Z., Zandkarimi, F., Liu, Y., Duan, S., Li, Z., Kon, N., Zhang, Z., Jiang, X., Stockwell, B. R., & Gu, W. (2023). Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metabolism, 35(8), 1474-1490.e8. https://doi.org/10.1016/j.cmet.2023.06.014
Publication Date